These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37742993)

  • 1. Non-small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.
    Karlow JA; Pehrsson EC; Xing X; Watson M; Devarakonda S; Govindan R; Wang T
    Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):991-1013. PubMed ID: 37742993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.
    Wang Q; Wu L; Yu J; Li G; Zhang P; Wang H; Shao L; Liu J; Shen W
    BMC Med Genomics; 2022 Mar; 15(1):66. PubMed ID: 35313869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
    Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
    J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining MeDIP-seq and MRE-seq to investigate genome-wide CpG methylation.
    Li D; Zhang B; Xing X; Wang T
    Methods; 2015 Jan; 72():29-40. PubMed ID: 25448294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer.
    Cho JW; Shim HS; Lee CY; Park SY; Hong MH; Lee I; Kim HR
    Exp Mol Med; 2022 Jan; 54(1):12-22. PubMed ID: 34987166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Whole DNA Methylome Analysis by Integrating MeDIP-seq and MRE-seq.
    Xing X; Zhang B; Li D; Wang T
    Methods Mol Biol; 2018; 1708():209-246. PubMed ID: 29224147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsaroucha E; Kakolyris S; Georgoulias V; Lianidou E
    Clin Chem Lab Med; 2016 Aug; 54(8):1385-93. PubMed ID: 26741346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
    Mansfield AS; Wang L; Cunningham JM; Jen J; Kolbert CP; Sun Z; Yang P
    Cancer Genet; 2015 May; 208(5):253-60. PubMed ID: 25650174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.
    Lee SM; Park JY; Kim DS
    Mol Cells; 2012 Aug; 34(2):171-6. PubMed ID: 22814847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
    Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
    Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
    Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
    Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts.
    Vizoso M; Puig M; Carmona FJ; Maqueda M; Velásquez A; Gómez A; Labernadie A; Lugo R; Gabasa M; Rigat-Brugarolas LG; Trepat X; Ramírez J; Moran S; Vidal E; Reguart N; Perera A; Esteller M; Alcaraz J
    Carcinogenesis; 2015 Dec; 36(12):1453-63. PubMed ID: 26449251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.